Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Sales | 391 | 556 | 474 | 441 | 326 |
| Cost of Goods | 164 | 231 | 199 | 183 | 149 |
| Gross Profit | 227 | 325 | 275 | 258 | 177 |
| Operating Expenses | 1,116 | 1,183 | 1,173 | 1,258 | 1,290 |
| Operating Income | -725 | -627 | -699 | -817 | -964 |
| Interest Expense | 70 | 62 | 52 | 41 | 38 |
| Other Income | -3 | 0 | -5 | 1 | 0 |
| Pre-tax Income | -798 | -689 | -756 | -857 | -1,002 |
| Net Income Continuous | -798 | -689 | -756 | -857 | -1,002 |
| Net Income | $-798 | $-689 | $-756 | $-857 | $-1,002 |
| EPS Basic Total Ops | -0.01 | -0.01 | N/A | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | N/A | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | -0.01 | N/A | N/A |
| EBITDA(a) | $-725 | $-627 | $-661 | $-781 | $-927 |